EIF2AK3 (also known as PERK, Protein Kinase RNA-like ER Kinase) is an endoplasmic reticulum (ER) transmembrane protein that plays a central role in the Integrated Stress Response (ISR). As one of four eIF2α kinases (along with PKR, GCN2, and HRI), PERK senses various cellular stresses and coordinates adaptive responses including translational attenuation, transcriptional regulation, and autophagy. PERK dysfunction is implicated in a broad spectrum of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple proteinopathies.
[1]
| Property | Value | [2]
|----------|-------| [3]
| Protein Name | PERK (Protein Kinase RNA-like ER Kinase) | [4]
| Gene Symbol | EIF2AK3 | [5]
| UniProt ID | Q9BXJ6 | [6]
| PDB ID | 3HVC | [7]
| Molecular Weight | ~165 kDa (1448 amino acids) | [8]
| Subcellular Localization | Endoplasmic reticulum membrane | [9]
| Protein Family | eIF2α kinase family | [10]
The EIF2AK3 Protein (PERK) is a type I transmembrane protein localized to the ER membrane, where it serves as a master regulator of cellular stress responses. Under normal conditions, PERK exists as an inactive monomer. Upon accumulation of misfolded proteins in the ER lumen (a condition known as ER stress), PERK undergoes oligomerization and autophosphorylation, activating its cytoplasmic kinase domain. Activated PERK phosphorylates eukaryotic translation initiation factor 2α (eIF2α) at Ser51, shifting the cellular translational program toward expression of stress response genes while suppressing general protein synthesis [2:1].
This mechanism is evolutionarily conserved and allows cells to:
PERK mutations cause Wolcott-Rallison syndrome, a rare autosomal recessive disorder characterized by neonatal diabetes, epiphyseal dysplasia, and neurological complications [1:1]. In neurodegeneration, PERK dysregulation contributes to synaptic loss, protein aggregation, and neuronal death.
PERK possesses a distinctive multi-domain structure:
Lumenal Domain (1-500 aa): N-terminal stress-sensing domain facing the ER lumen
Transmembrane Domain (500-530 aa): Single-pass membrane anchor
**Kinase Domain (530-890 aa): Cytoplasmic serine/threonine kinase
**C-terminal Domain (890-1448 aa): Regulatory region
PERK activation follows a stepwise mechanism:
PERK is one of four eIF2α kinases that initiate the Integrated Stress Response [5:1]:
| Kinase | Primary Stress | Location |
|---|---|---|
| PERK | ER stress | ER membrane |
| GCN2 | Amino acid deprivation | Cytoplasm |
| PKR | Viral infection | Cytoplasm |
| HRI | Heme deprivation | Cytoplasm |
All four kinases converge on eIF2α phosphorylation, creating a unified response to diverse stresses.
PERK-mediated eIF2α phosphorylation [11]:
The PERK-eIF2α-ATF4 pathway activates [12]:
PERK activates autophagy through multiple mechanisms [13]:
PERK dysregulation is a hallmark of AD pathogenesis [7:1]:
PERK contributes to PD pathogenesis [8:1]:
PERK is implicated in ALS pathogenesis [6:1]:
PERK contributes to synaptic failure through multiple pathways [16]:
PERK intersects with protein aggregation pathways [17]:
PERK modulates neuroinflammatory responses [18]:
Prolonged PERK activation triggers apoptotic cell death:
Several PERK inhibitors are in development [19]:
| Compound | Specificity | Stage | Indication |
|---|---|---|---|
| GSK2656157 | PERK | Preclinical | AD, PD |
| ATLAS-106 | PERK | Preclinical | ALS |
| MKC8866 | PERK | Preclinical | PD |
| Compound 6 | PERK | Research | Various |
Rather than direct PERK inhibition, ISR modulators show promise:
| Partner | Interaction | Function |
|---|---|---|
| BiP/GRP78 | Binding | ER chaperone, negative regulator |
| eIF2α | Phosphorylation | Translation initiation factor |
| ATF4 | Transcription | Stress response transcription factor |
| CHOP | Regulation | Pro-apoptotic transcription factor |
| XBP1 | Activation | Unfolded protein response |
| GADD34 | Feedback | eIF2α phosphatase subunit |
| PERK | Self | Dimerization, activation |
| mTORC1 | Cross-talk | Translation regulation |
EIF2AK3 (PERK) is an ER transmembrane kinase that initiates the Integrated Stress Response upon accumulation of misfolded proteins. PERK phosphorylates eIF2α, attenuating global translation while upregulating stress response genes including ATF4 and CHOP. In neurodegenerative diseases, PERK dysregulation contributes to synaptic loss, protein aggregation, and neuronal death through these pathways. PERK is implicated in Alzheimer's disease (tau phosphorylation, synaptic dysfunction), Parkinson's disease (α-synuclein toxicity, dopaminergic apoptosis), and ALS (TDP-43 pathology). PERK inhibitors and ISR modulators represent therapeutic strategies currently in development.
The study of EIF2AK3 has revealed critical insights into cellular stress responses:
Research continues to clarify PERK's role in neurodegeneration and develop targeted therapeutics.